OP
ASND icon

ORG Partners’s Ascendis Pharma A/S ASND Stock Holding History

ORG Partners’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6
Closed -$1.03K – 1590
2025
Q2 		$1.03K Hold
6
– – ﹤0.01% 1331
2025
Q1 		$908 Buy
+6
New +$857 ﹤0.01% 1189

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ORG Partners's ASND Position: Q3 2025 in Review

ORG Partners sold out of Ascendis Pharma A/S (ASND) in Q3 2025, closing a stake of 6 shares — an estimated $1.03K sold.

ORG Partners first reported a position in ASND in Q1 2025 and held it in 2 quarters. The position peaked at $1.03K in Q2 2025. 279 funds tracked by Wall St. Rank hold ASND as of Q3 2025.

  • ORG Partners reported no remaining Ascendis Pharma A/S position as of Q3 2025 after selling out during the quarter.
  • ORG Partners sold 6 Ascendis Pharma A/S shares in Q3 2025, an estimated $1.03K.
  • ORG Partners first reported a position in Ascendis Pharma A/S in Q1 2025 and held it in 2 quarters.
  • ORG Partners's Ascendis Pharma A/S position peaked at $1.03K in Q2 2025.
  • 279 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2025.

Based on ORG Partners's 13F filing for Q3 2025, filed 24 Oct 2025.